Michael Dennis Price Net Worth

What's Michael Price's mailing address?

Michael's mailing address filed with the SEC is 1800 W Georgia St, Vancouver, BC V6G 2L3, Canada.

Insiders trading at Akcea Therapeutics Inc

Over the last 7 years, insiders at Akcea Therapeutics Inc have traded over $384,023 worth of Akcea Therapeutics Inc stock and bought 35,029,381 units worth $610,464,515 . The most active insiders traders include Pharmaceuticals Inc Ionis, Paula Soteropoulos, eB Lynne Parshall. On average, Akcea Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $40,228,816. The most recent stock trade was executed by Pharmaceuticals Inc Ionis on 10 October 2020, trading 21,237,715 units of AKCA stock currently worth $385,464,527.

What does Akcea Therapeutics Inc do?

Akcea Therapeutics Inc executives and stock owners

Akcea Therapeutics Inc executives and other stock owners filed with the SEC include:

• Barbara Yanni,
  Director
• Amber Salzman,
  Director
• Joseph Iii Klein,
  Director
• Michael J. Yang,
  Director
• Pharmaceuticals Inc Ionis,
  10% owner
• Michael F Mac Lean,
  Chief Financial Officer
• Jeff Marc Goldberg,
  Chief Operating Officer
• Louis O'dea,
  Chief Medical Officer
• Paula Soteropoulos,
  Chief Executive Officer
• Elaine Hochberg,
  Director
• Edward M Fitzgerald,
  Director
• Sandford D Smith,
  Director
• Richard A Moscicki,
  Director
• Sarah Boyce,
  President
• Christopher Gabrieli,
  Director
• Alex G. Howarth,
  Chief Operating Officer
• B Lynne Parshall,
  Director
• Kyle Jenne,
  Chief Commercial Officer
• Michael Dennis Price,
  Chief Financial Officer
• Damien Mc Devitt,
  Chief Executive Officer
• Joshua F. Patterson,
  General Counsel
• William T. Andrews,
  Chief Medical Officer